CARD11 (and why it matters)
**What it means:** CARD11 is a **scaffold protein** — it acts like a docking station that brings inflammatory signaling molecules together. When a microglial receptor detects a threat, CARD11 assemble...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
First-in-Human (FIH) Trial
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
FDA Approval Precedent (for gene therapy)
**What it means:** The fact that seven AAV-based gene therapies have received FDA approval provides a regulatory pathway that the MEF2C gene therapy team can follow. FDA has extensive experience revie...
Synthetic Biology (in gene therapy context)
**What it means:** Synthetic biology is the field of engineering biological components and systems that don't exist in nature. In gene therapy, this includes designing custom viral vectors, optimizing...
Patient-Derived (in cell biology context)
**What it means:** "Patient-derived" means cells, tissues, or samples that were taken **directly from a patient** (usually via biopsy or blood draw) and used in research. This is different from cancer...
Oncologic Biomarker Context for MHS
**What it means:** A biomarker is a measurable biological indicator. In cancer, biomarkers (like ctDNA, tumor size on imaging, or protein levels in blood) tell doctors how the cancer is responding to ...
Germline Mosaicism (rare inheritance mechanism)
**What it means:** Germline mosaicism is a rare phenomenon where a parent has a mutation in some of their reproductive cells (sperm or eggs) but NOT in their body cells. This means the parent tested "...
Blood-Brain Barrier (BBB) Penetrance
The Blood-Brain Barrier (BBB) is like a **military checkpoint** between your bloodstream and your brain. It's made of tightly packed cells with no gaps — designed to keep toxins out. But it also keeps...
Microglial Synaptic Pruning
**What it means:** During brain development, the brain makes way more synaptic connections than it needs — like building more roads than necessary. **Microglia** (the brain's immune cells) act as "pru...
Behavioral Brain Research Foundation (BDRF)
**What it means:** The BDRF is a **private foundation** that funds neuroscience research. Their "Distinguished Investigative Grant" is a significant award given to researchers who have demonstrated ex...
ADAMDEC1 (and why it matters)
**What it means:** ADAMDEC1 is a **metalloprotease** — a protein-cutting enzyme that remodels the **extracellular matrix** (the structural scaffolding that holds brain cells in place). Think of it as ...
Base Editing
**What it means:** Base editing is a precise gene-editing technique that changes a single DNA letter (like turning an A into a G) without cutting both strands of the DNA helix (which is how traditiona...
BDNF (Brain-Derived Neurotrophic Factor)
**What it means:** BDNF is a protein that acts like **fertilizer for neurons** — it promotes neuronal survival, growth, and synaptic plasticity. Without enough BDNF, neurons are fragile and connection...
GRIN2B (NMDA Receptor)
**What it means:** GRIN2B (also known as NR2B) is a subunit of the **NMDA-type glutamate receptor**, which is critical for synaptic plasticity — the brain's ability to strengthen or weaken connections...
MEF2 (the family, not just MEF2C)
**What it means:** MEF2C is one member of a family of four related transcription factors: MEF2A, MEF2B, MEF2C, and MEF2D. They all share a similar DNA-binding domain (the "MADS-box"), which is why the...
Retinal (eye) in the context of gene therapy
**What it means:** The retina (the light-sensitive layer at the back of the eye) was actually the **first tissue** where gene therapy succeeded (Luxturna, 2017). The eye is "immune-privileged" — meani...
Serotype (AAV Serotype)
**What it means:** AAV isn't a single virus — it's a family of related viruses, each called a **serotype**. Different serotypes have different **tissue preferences** — some are better at reaching the ...
iPSC (Induced Pluripotent Stem Cell)
**What it means:** iPSCs are adult cells (like skin cells) that have been **reprogrammed** back to an embryonic-like state — they can become any cell type in the body. It's like hitting the "reset but...
EpiSign (Methylation Defects testing platform)
**What it means:** EpiSign is a commercial testing platform that analyzes genome-wide DNA methylation patterns to identify disease-specific "epigenetic signatures." It's like a fingerprint — each gene...
Methylation / DNA Methylation
**What it means:** DNA methylation is an **epigenetic** process — it doesn't change the DNA sequence itself, but adds chemical "tags" (methyl groups) to the DNA that tell genes to be more or less acti...
ctDNA (Circulating Tumor DNA)
**What it means:** Tumors shed tiny fragments of their DNA into the bloodstream — this is "circulating tumor DNA." By measuring ctDNA levels in a blood draw (a "liquid biopsy"), doctors can track canc...
Blood-Brain Barrier (BBB)
**What it means:** The BBB is an ultra-tight layer of cells lining the brain's blood vessels. Think of it like a **super-filter** or a nightclub with an extremely strict bouncer — it lets nutrients an...